Sunko Ink Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Sunko Ink's earnings have been declining at an average annual rate of -51.4%, while the Chemicals industry saw earnings growing at 7.8% annually. Revenues have been declining at an average rate of 6.9% per year.

Wichtige Informationen

-51.4%

Wachstumsrate der Gewinne

-51.4%

EPS-Wachstumsrate

Chemicals Wachstum der Industrie7.9%
Wachstumsrate der Einnahmen-6.9%
Eigenkapitalrendite-13.3%
Netto-Marge-11.7%
Letzte Ertragsaktualisierung30 Jun 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Is Sunko Ink (TWSE:1721) A Risky Investment?

Oct 11
Is Sunko Ink (TWSE:1721) A Risky Investment?

Revenues Not Telling The Story For Sunko Ink Co., Ltd. (TWSE:1721) After Shares Rise 27%

Sep 05
Revenues Not Telling The Story For Sunko Ink Co., Ltd. (TWSE:1721) After Shares Rise 27%

Would Sunko Ink (TWSE:1721) Be Better Off With Less Debt?

Feb 27
Would Sunko Ink (TWSE:1721) Be Better Off With Less Debt?

Is It Worth Buying Sunko Ink Co., Ltd. (TPE:1721) For Its 4.6% Dividend Yield?

Mar 30
Is It Worth Buying Sunko Ink Co., Ltd. (TPE:1721) For Its 4.6% Dividend Yield?

Sunko Ink (TPE:1721) Has Debt But No Earnings; Should You Worry?

Feb 22
Sunko Ink (TPE:1721) Has Debt But No Earnings; Should You Worry?

A Look At Sunko Ink's (TPE:1721) Share Price Returns

Jan 17
A Look At Sunko Ink's (TPE:1721) Share Price Returns

Should You Rely On Sunko Ink's (TPE:1721) Earnings Growth?

Dec 13
Should You Rely On Sunko Ink's (TPE:1721) Earnings Growth?

Aufschlüsselung der Einnahmen und Ausgaben

Wie Sunko Ink Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

TWSE:1721 Einnahmen, Ausgaben und Erträge (TWD Millions)
DatumEinnahmenUmsatzAllgemeine und VerwaltungskostenF&E-Ausgaben
30 Jun 242,259-26415247
31 Mar 242,150-30415047
31 Dec 232,186-27815047
30 Sep 232,302-23614248
30 Jun 232,432-15215149
31 Mar 232,787-1916650
31 Dec 223,0096117350
30 Sep 223,14112419051
30 Jun 223,0893318050
31 Mar 222,921-417251
31 Dec 212,851-7017351
30 Sep 212,646-16116551
30 Jun 212,667-9817151
31 Mar 212,64949630553
31 Dec 202,75352432954
30 Sep 202,92156834556
30 Jun 203,11657535057
31 Mar 203,214-4322557
31 Dec 193,244-720856
30 Sep 193,2951121456
30 Jun 193,3573122356
31 Mar 193,4905322656
31 Dec 183,4521623057
30 Sep 183,4973422958
30 Jun 183,5007022057
31 Mar 183,3424622055
31 Dec 173,4097022349
30 Sep 173,33512623546
30 Jun 173,27110323644
31 Mar 173,42318527947
31 Dec 163,57923129254
30 Sep 163,75916930959
30 Jun 163,92618135460
31 Mar 164,08012835458
31 Dec 154,0649536155
30 Sep 153,4537731642
30 Jun 152,8414124731
31 Mar 152,1632319026
31 Dec 141,578814816
30 Sep 141,602-317716
30 Jun 141,663717515
31 Mar 141,751917215
31 Dec 131,709516819

Qualität der Erträge: 1721 is currently unprofitable.

Wachsende Gewinnspanne: 1721 is currently unprofitable.


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 1721 is unprofitable, and losses have increased over the past 5 years at a rate of 51.4% per year.

Beschleunigtes Wachstum: Unable to compare 1721's earnings growth over the past year to its 5-year average as it is currently unprofitable

Erträge im Vergleich zur Industrie: 1721 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (15.6%).


Eigenkapitalrendite

Hohe Eigenkapitalrendite: 1721 has a negative Return on Equity (-13.27%), as it is currently unprofitable.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren